Prescription drug · ANDA
Butalbital, Acetaminophen And Caffeine NDC 80425-0497
Butalbital 50 mg/1 + 2 more ingredients · Capsule · Oral · Advanced Rx of Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 80425-0497-1 | 80425049701 | 30 CAPSULE in 1 BOTTLE (80425-0497-1)Marketed from Feb 14, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Butalbital, Acetaminophen And Caffeine
- Generic name (nonproprietary)
- butalbital, acetaminophen and caffeine
- Active ingredients
- Butalbital — 50 mg/1Acetaminophen — 300 mg/1Caffeine — 40 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214087
- Marketing start
- Listing expires
- DEA schedule
- CIII
- Other FDA classes
- Barbiturates (Chemical structure)Central Nervous System Stimulation (Physiologic effect)Xanthines (Chemical structure)
- Identifiers
- Product ID 80425-0497_2e20e0f9-ff3c-5d55-e063-6294a90a13ebSPL ID 2e20e0f9-ff3c-5d55-e063-6294a90a13ebSPL set ID 2e20e0ee-dd73-6287-e063-6294a90a03b1RxCUI 889520UNII KHS0AZ4JVK, 362O9ITL9D, 3G6A5W338E
- Pharmacologic class
- Barbiturate; Central Nervous System Stimulant; Methylxanthine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N480425049701followed by a unit qualifier and the quantityPackage 80425-0497-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Butalbital, acetaminophen and caffeine capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 214087
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Butalbital, Acetaminophen And Caffeine | Butalbital 50 mg/1 + 2 more ingredients | CapsuleOral | Seton Pharmaceuticals LLC | 13925-535 |
| Butalbital, Acetaminophen And Caffeine | Butalbital 50 mg/1 + 2 more ingredients | CapsuleOral | Seton Pharmaceuticals LLC | 13925-536 |
| Butalbital, Acetaminophen And Caffeine | Butalbital 50 mg/1 + 2 more ingredients | CapsuleOral | SOLCO HEALTHCARE US, LLC | 43547-686 |
| Butalbital, Acetaminophen And Caffeine | Butalbital 50 mg/1 + 2 more ingredients | CapsuleOral | Amici Pharma, Inc. | 69292-305 |